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Objective: Children needing admission to an inpatient mental health unit often 
present with severe neuropsychiatric disorders characterised by complex 
psychopathology. We aimed to examine all admitted children with comorbid chronic 
tic disorder (CTD) and Tourette syndrome (TS) over a 10-year period and determine 
the clinical significance of these diagnoses. 
 
Method: A retrospective, naturalistic study was conducted, comparing children with 
and without CTD/TS in terms of co-morbid diagnoses, medication use, access to 
education, aggression contributing to the admission, duration of admission, 
functional outcomes, and satisfaction with treatment. Data were analysed using Chi-
square/Fisher’s exact test and t-test for categorical and continuous variables, 
respectively, and subsequently with unadjusted and adjusted linear and logistic 
regression analyses. 
 
Results: A relatively high proportion of children had co-morbid CTD/TS (19.7%). 
There was a significant association with co-morbid obsessive-compulsive disorder, 
intellectual disability and autism spectrum disorder but not attention deficit 
hyperactivity disorder. CTD/TS were associated with longer admissions even after 
adjustments for confounding but did not seem to be independently associated with 




Conclusions: The prevalence of CTD/TS in children needing inpatient treatment is 
significant.  In our sample, comorbid CTD/TS seem to represent a marker of overall 
































Children in need of admission to an inpatient mental health unit often present with 
severe neuropsychiatric disorders characterised by complex psychopathology in 
multiple domains (Kyriakopoulos et al, 2015; Green et al 2007). Among their 
symptoms, admitted children occasionally present with comorbid tic disorders, a 
group of phenomenologically heterogeneous neuropsychiatric conditions that involve 
rapid, repetitive, involuntary movements or vocalisations (Efron and Dale, 2018). Of 
these, Tourette syndrome (TS) is the most severe and extensively researched. TS is 
characterised by the presence of both motor and vocal tics, for a period of at least 
one year without periods of tic remission lasting more than two months (World Health 
Organization, 2018). Motor tics include simple movements such as eye blinking, 
facial grimacing, arm, trunk, or leg movements, or more complex whole-body 
movements, including inappropriate gestures (copropraxia). Vocal tics include simple 
noises such as throat clearing, humming, sniffing, squeaking or more complex 
vocalisations including words, repeating phrases, or even swear words (coprolalia) 
(Leckman, 2003). The prevalence of TS is estimated at 0.3-0.8% of school age 
children (Scahill et al., 2005; Hirtz et al., 2007) and has been associated with a wide 
range of neurodevelopmental and mental health conditions including attention deficit 
hyperactivity disorder (ADHD), autism spectrum disorders (ASD), obsessive 
compulsive disorder (OCD) and other anxiety disorders, as well as challenging 
behaviours and aggressive outbursts (Swain et al, 2007). Hirschtritt and colleagues 
(2015) found that the estimated lifetime prevalence of any psychiatric comorbidity in 
TS is 85.7%. Alongside TS, chronic motor or vocal tic disorder (CTD) is 
characterised by the same tic duration criteria but tics are either motor or vocal, not 
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both. CTD is more common than TS with an estimated prevalence of 0.5 – 1.1% 
(Scharf et al, 2012) but less researched in terms of its associated psychopathology.  
The severity of tics can range from mild, which can occur without much apparent 
consequence to the child's overall psychopathology, to severe which are disabling 
and affect all aspects of functioning, requiring specific interventions in their own right 
(Leckman et al, 1989). In mixed neurodevelopmental presentations, tics, especially 
when mild in intensity, may not always be considered as a significant factor in the 
decision-making process of the child's treatment and overall management (Ernberg 
et al, 1987; Storch et al, 2007). Indeed, there is no evidence to recommend that the 
treatment of comorbid developmental disorders should differ between those with and 
without tics (Bloch and Leckman, 2009). 
 
The main symptomatology of children with severe disorders needing inpatient 
treatment is not commonly identified as being directly linked with comorbid TS or 
CTD. As such, the relative significance of the presence of tics in these children has 
not been studied to date. The aim of this study was to examine the demographic and 
clinical characteristics of children with comorbid CTD/TS up to the age of 12 years 
admitted to a children's inpatient mental health unit, and to evaluate the clinical 
significance of CTD/TS on their overall treatment, educational and functional 
outcomes, duration of admission, and satisfaction with the input they received. We 
hypothesised that comorbid CTD/TS would be associated with higher illness burden, 
lengthier admissions, and higher levels of associated aggression compared to 






A retrospective naturalistic study was conducted of all patients discharged from a 
national inpatient children’s mental health unit between the years 2009 to 2019 
during their admission. The unit provides inpatient assessment and treatment for 
children aged up to 13 years with severe and complex disorders. These include 
children with neuropsychiatric disorders such as autism spectrum disorders (ASD) 
and attention deficit hyperactivity disorder (ADHD), depression, very early onset 
psychosis and bipolar affective disorder, obsessive-compulsive disorder, eating 
disorders, stress-related disorders, and complicated diagnostic conditions. The 
service is one of only eight child inpatient units in England and Wales. More 
information about this can be found in a previous publication (Kyriakopoulos et al, 
2015). 
 
Children with comorbid Chronic Tic disorder or Tourette syndrome (CTT group) were 
identified and compared with the remaining children (No chronic Tic disorder or 
Tourette syndrome: NTT group) in terms of age, gender, medication on admission 
and discharge, whether they were in education on admission and discharge, whether 
aggression, as reported in the referral information and history from families, 
contributed towards their admission, duration of admission, functional outcomes, and 
satisfaction with treatment. Tics and their duration were identified through clinical 
observations recorded in the electronic notes system and history from the child’s 
family included in clinical reports. If criteria for the diagnoses of CTD or TS were met, 
the child was included in the CTT group. The CGAS (Children’s Global Assessment 
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Scale) on admission and at discharge was used to assess global functioning (Shaffer 
et al, 1983). It takes values from 1, representing the lowest level of functioning, to 
100, representing the highest. This scale was recorded by the unit’s team in a way 
that was blinded to the purpose of the current study. Not being in education was 
defined as not attending school for more than 50% of the time for at least two weeks 
prior to admission or not having an educational setting identified at discharge. 
Diagnoses were made in accordance with the Multiaxial ICD-10 classification of child 
and adolescent psychiatric disorders (World Health Organization, 1996) and the ICD-
10 diagnostic criteria for research (World Health Organization, 1993), and additional 
diagnostic assessments as appropriate, including the Autism diagnostic observation 
schedule (ADOS; Lord et al, 1989), the Autism Diagnostic Interview-Revised (ADI-R; 
Lord et al, 1994), and Conners questionnaires (Conners et al, 1998). Children and 
parent/carer satisfaction were measured using the Acorn Satisfaction Questionnaire 
(ASQ) at discharge. The ASQ is a 9-item self-report measure (7 items for 
parents/carers and 2 items for children) which has been previously used with 
children with mental health difficulties requiring inpatient admission (Kyriakopoulos et 
al., 2015). Each item is rated on a Likert scale from 1 to 5, with higher scores 




Data were analysed initially using Chi-square/Fisher’s exact test and t-tests for 
categorical and continuous variables, respectively. CTT and NTT were also 
compared in terms of their comorbid diagnoses to determine the likelihood of 
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comorbidity with tics. ADHD, OCD, ASD, intellectual disability (ID), and aggression 
were specifically examined. Next, a series of unadjusted (Model A) and multiple 
regression analyses (Model B) were performed to examine the associations between 
the CTT group and all sociodemographic and clinical characteristics before and after 
adjustments for confounding. The NTT group served as the reference category in all 
regression models. Covariates in Model B included age, gender, and comorbid 
disorders including ID, ASD, ADHD, and OCD. Linear regression analyses were 
performed for continuous outcome variables (functional outcomes at admission and 
discharge, child and parent/carer satisfaction, and duration of treatment) and logistic 
regression analyses for binary outcomes (medication at admission and discharge, 
education on admission and discharge, and presenting with aggression on 
admission). The regression coefficients were accordingly expressed as 
unstandardised beta (β) values or Odds ratios (OR). Analyses were performed using 
the IBM Statistical Package for Social Sciences (SPSS) version 26.0 and Stata/MP 
16.1. 
 
This study was part of a service evaluation project which was approved by the South 
London and Maudsley NHS Foundation Trust Child and Adolescent Mental Health 







During the study period, a total of 218 children were discharged from our unit (45.9% 
female) and their admission data were included in this analysis. Forty-three patients 
were in the CTT group (19.7%) and 175 were in the NTT group (80.3%). CTT 
compared to NTT were more likely to be male at a trend level (χ2 = 3.824, df = 1, p = 
0.051), receive medication on admission (χ2 = 5.655, df = 1, p = 0.017) and at 
discharge (χ2 = 6.106, df = 1, p = 0.013), present with aggression contributing to their 
admission (χ2 = 4.944, df = 1, p = 0.026) and have longer admission (t = -2.763, p = 
0.008). No significant differences were found between the CTT group and NTT group 
in terms of age on admission (t = 0.35, p = 0.727), education on admission (χ2 = 
1.261, df = 1, p = 0.262), education at discharge (Fisher’s exact test p = 1.0), mean 
CGAS score on admission (t = 0.981, p = 0.328) and at discharge (t = 1.374, p = 
0.171), mean CGAS score change (t = 0 .491, p = 0.624), parent/carer satisfaction (t 
= 0.454, df = 187, p = 0.65) or child satisfaction with treatment (t =  -0.651, df = 166, 
p = 0.516). Table 1 summarises the demographic and clinical characteristics 
examined. 
 
In the CTT group, 81.4% of children (35/43) had a comorbid ASD diagnosis 
compared with 48% (84/175) in the NTT group (χ2 = 15.529, df = 1, p > 0.001), 
30.2% (13/43) had a diagnosis of ADHD compared with 25.1% (44/175) in the NTT 
group (χ2 = 0.463, df = 1, p = 0.496), 27.9% (12/43) had a diagnosis of OCD 
compared with 12.6% (22/175) in the NTT group (χ2 = 6.167, df = 1, p = 0.013), and 
30.2% (13/43) had a comorbid diagnosis of ID compared with 10.6% (19/175) in the 




Tables 3 and 4 summarise the results of the continuous and logistic regression 
models, respectively. Of the significant associations in the unadjusted linear 
regression model between CTT group membership and medication on admission 
and at discharge, aggression contributing to admission, and duration of admission, 
only the relationship with duration of admission remained statistically significant in 
the adjusted linear regression models (β=51.34, p<.01). The significant bivariate 
associations between CTT group membership and the remaining outcomes were 
explained by presence of comorbid diagnoses. Specifically, a  diagnosis of ADHD 
was associated with increased odds for receiving medication on admission 
(OR=6.34, 95%CI 2.69-14.94) and discharge (OR=8.73, 95%CI 1.85-41.15), and 
presenting with aggression prior to admission (OR=6.38, 95%CI 1.81-22.54). A 
diagnosis of ASD was associated with increased odds for receiving medication on 
discharge (OR=3.45, 95%CI 1.49-7.99) and for having aggression contributing to 




In this naturalistic study, we systematically examined during their admission all 
children discharged from a national children’s inpatient mental health unit over a ten-
year period. Given the unique sample of patients admitted, we expected and noted 
that our sample had a relatively high proportion of children with comorbid CTD/TS 
(19.7%), as compared with the general population where population prevalence of 
TS and CTD is 0.3-0.8% and  0.5-1.1 respectively (Scharf et al, 2012). Our interest 
was in closely examining this group of children to determine the clinical correlates 
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and characteristics associated with the prevalence of CTD/TS, and to determine 
whether these conditions impacted on their overall functioning and morbidity.  
 
Clinical profile of children with CTD/TS 
 
Children with CTD/TS displayed greater neurodevelopmental deviance as was 
demonstrated by the significant association with a comorbid ASD, OCD, and ID. This 
is in keeping with previous studies; Robertson (2000) noted a strong association 
between OCD and TS, reporting that up to 40% of patients with TS report comorbid 
obsessive-compulsive symptoms and behaviours. OCD has been identified as one of 
the most frequent comorbidities in TS with its prevalence ranging from 10% to 66% 
in this group of patients (Cravedi et al., 2017; Hirschtritt et al, 2015; Sambrani et al, 
2016). In our sample, the prevalence of comorbid OCD with CTD/TS was 27.9%, 
similar to recent findings from Gorman and colleagues (2010) at 25% and Eapen and 
colleagues (2016) at 35%. Studies have also consistently shown an association 
between TS and ID. Estimates vary from as little as 5.4% (Byler et al, 2015) to 24- 
27% (Eapen et al, 2016, Gorman et al 2010). An analysis of 5450 subjects in the 
‘TIC’ database (Burd et al, 2005) estimated a 22.7% prevalence of ID. These are 
broadly consistent with our findings, though notably we found a higher prevalence of 
comorbid CTD/TS with ID, at 30.2%, in children requiring hospital admission. 
 
It is of note that in our cohort the prevalence of ASD in CTD/TS was 81.4% which is 
significantly higher than in outpatient samples. Two large clinical cohorts of TS 
patients and their families were screened for the presence of ASD symptoms and 
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identified a ‘probable’ incidence of ASD of about 20% in this group (Darrow et al, 
2017; Huisman-van Dijk et al, 2016). A recent study by Eapen and colleagues (2016) 
in subjects with an established diagnosis of TS who were asked to report on 
established comorbid diagnoses found that ASD was reported in 21% of children. 
This is higher than previous incidence reports ranging from 2.9% to 4.9% in clinical 
populations (Burd et al, 2009 and Ghanizadeh and Mosallaei, 2008). The large 
difference between our sample and outpatient samples may reflect the fact that 
children with ASD needing inpatient input are more likely to present with more 
severe symptoms and multiple comorbidities, frequently including chronic tics and 
TS.  
 
Interestingly, we did not find a significant association between CTD/TS and ADHD. 
Research into TS and ADHD has shown frequent co-occurrence of the two 
disorders, with studies suggesting comorbidity rates ranging between 21 to 90% in 
studied cohorts (Robertson, 2006). Oluwabusi and colleagues (2016) also found that 
between 35-90% of children with TS present with ADHD symptoms.  A meta-analysis 
of genome-wide association studies of ADHD and TS has found evidence of a 
common genetic background and that specific genes may underlie both disorders 
(Tsetsos et al, 2016).  One possible reason why our study did not pick up this 
association may be related to the relatively low proportion of patients admitted to our 
ward with ADHD (26%).  
 
The presence of CTD/TS was also significantly associated with aggression in our 
sample. However, this relationship seems to be driven by comorbid ADHD and ASD 
14 
 
rather than being a direct effect of tics. A complex interplay of aetiological factors is 
believed to contribute to aggression in TS, including genetic, neurobiological and 
environmental factors (Budman, 2015). The majority of studies examining the 
association between TS and aggression, support a link between the two 
(Ghanizadeh & Mosallaei, 2009, Cavanna et al 2014; Wright et al, 2012). One study 
that compared children with TS-alone to those with TS with comorbidity suggested 
that aggression is related to the increase symptom burden associated with 
comorbidity rather than tics (Benaroya-Milshtein et al, 2020). A diagnosis of TS and 
comorbid ADHD is thought to be strongly associated with aggression, again 
supporting the notion that it is the comorbidity that is associated with aggression 
rather than the presence of CTD/TS (Budman et al, 2015). However, another study 
suggested a more direct relationship between tic severity and aggression (Robertson 
et al, 2015). Further research including larger samples may shed more light into the 
possibility of tics independently contributing to aggressive behaviours when 
comorbid with other neurodevelopmental or mental health conditions.  
 
Children with comorbid CTD and TS had similar gains in global functioning to 
children without these presentations during their admission but stayed in hospital for 
longer. Satisfaction with treatment also seems not to be independently associated 
with comorbid CTD and TS despite the need for additional treatment and may reflect 
this level of overall improvement. However, longer admissions suggest an additional 
symptom burden and need for more extended interventions to achieve the same 
functional outcomes in this group. The literature into the association between 
CTD/TS and functional impairment is inconclusive.  In some studies, TS has been 
associated with significantly worse quality of life outcomes than the general 
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population, particularly in the adult literature (Eddy et al, 2011; Elstner et al, 2001) 
and research to date indicates that severe forms of TS may impact on home, 
school/work life, education, gaining independence and relationships with family and 
friends (Eapen et al 2016). However, other studies have suggested that the 
impairment may be due to comorbidities, rather than tics alone (Coffey et al, 2004, 
Robertson et al, 2015). One study comparing TS patients with comorbidities to those 
without have shown that those with TS with comorbidities, particularly ADHD, exhibit 
higher levels of cognitive and behavioural disability than children with TS alone 
(Rizzo et al, 2007). Other studies have noted that patients with TS with comorbidity 
did not necessarily exhibit greater tic severity and that tic severity was not associated 
with a greater number of comorbidities (Specht et al, 2011). This suggests a more 
complex relationship exists between the presence of tics, comorbidities and resulting 
impairment.  
 
Strengths and Limitations    
 
A considerable strength of our study is the that our sample spans ten years and 
offers an insight into the demographics and clinical characteristics of this unique 
population of young children requiring inpatient care. Limitations include the 
relatively small sample size, and the retrospective nature of our investigation which 
did not allow for the prospective quantification of the severity and impact of tics with 
the use of a validated scale. Although selection bias is one of the limitations of 
retrospective studies, we feel it is less likely in our investigation as tics were 
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evaluated independently of the children’s comorbid diagnoses which were recorded 




The prevalence of CTD/TS in children needing inpatient treatment is significant.  In 
our sample, comorbid CTD/TS seem to represent a marker of overall symptom 
severity as is evidenced by longer hospital admissions. CTD/TS did not seem to be 
independently associated with medication use, aggression contributing to the 
children’s admission, functional outcomes, or satisfaction with treatment after 
adjustments for comorbid disorders. This may suggest that the additional clinical 
burden of these tic disorders in children requiring mental health hospitalisation is 
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Table 1. Demographic and clinical characteristics of children with Chronic Tic 
Disorder or Tourette syndrome (CTT) and without (No chronic Tic disorder or 
Tourette syndrome: NTT) 
 CTT 
N = 43 
(19.7%) 
NTT 
N = 175  
(80.3%) 
p value 
Female (%) 14 (32.5) 86 (49.1) 0.051 
Mean age in years (SD) 10.7 (1.6) 10.8 (1.7) 0.350 
Medication on admission N (%) 31 (72.1) 91 (52) 0.017* 
Medication on discharge N (%) 40 (93) 133 (76) 0.013* 
Not in education on admission N (%) 21 (48.8) 69 (39.4) 0.262 
Not in education on discharge N (%) 2 (4.7) 9 (5.1) 1.0 
Aggression contributed to admission 
N (%) 
37 (86) 121 (69.1)  0.026* 




135.1 (83.7) 0.008** 
CGAS on admission mean score 
(SD) 
25.3 (12.6) 27.5 (13.3) 0.328 
CGAS on discharge mean score (SD) 54.4 (12.6) 58.1 (16.7) 0.171 
CGAS change mean score (SD) 29.1 (17.6) 30.7 (19.7) 0.624 
Satisfaction Child*** - ASQ mean 
score (SD) 
7.9 (5.3) 7.5 (2.5) 0.663 
Satisfaction Parent/Carer*** - ASQ 
mean score (SD) 
30 (6.2) 30.5 (5.1) 0.65 
N: Number of children, ASQ: Acorn Satisfaction Questionnaire 
* p<0.05, **p<0.01 
*** ASQ data was available in the CTT group for 35 children (81.4%) and 36 
parents/carers (83.7%) and in the NTT group for 133 children (76%) and 153 





Table 2. Co-morbid diagnoses in children with Chronic Tic Disorder or Tourette 
syndrome (CTT) and without (No chronic Tic disorder or Tourette syndrome: NTT) 
 CTT 
N = 43  
(19.7%) 
NTT 
N = 175  
(80.3%) 
p value 
ASD (%) 35 (81.4) 84 (48) >0.001** 
ADHD (%) 13 (30.2) 44 (25.1) 0.496 
OCD (%) 12 (27.9) 22 (12.6) 0.013* 
ID (%) 13 (30.2) 19 (10.6) 0.001** 
 
ASD: autism spectrum disorder, ADHD: attention deficit hyperactivity disorder, OCD: 


















Table 3. Crude and adjusted unstandardised regression coefficients (SE) of linear regression models examining the associations 
between chronic tic disorder/Tourette syndrome (CTD/TS) with demographic and clinical characteristics 
 
 
CGAS on admission CGAS on discharge Child Satisfaction  
Parent/Carer 
Satisfaction  
Duration of admission 









































































































































Model A: Unadjusted coefficients 
Model B: Adjustments for age, gender, and diagnosis of ID, ASD, ADHD or OCD  
ADHD: Attention deficit hyperactivity disorder; ASD: Autism spectrum disorder; CTD/TS: chronic tic disorder/Tourette syndrome; ID: 






Table 4. Crude and adjusted unstandardised odds ratios (OR; 95% CI) of logistic regression models examining the associations 
between chronic tic disorder/Tourette syndrome (CTD/TS) with demographic and clinical characteristics 





In education on 
admission 
In education on 
discharge 
 Model A 
OR 
(95%CI) 

















































































































































































Model A: Unadjusted coefficients 
Model B: Adjustments for age, gender, and diagnosis of ID, ASD, ADHD or OCD  
ADHD: Attention deficit hyperactivity disorder; ASD: Autism spectrum disorder; CTD/TS: chronic tic disorder/Tourette syndrome; ID: 
Intellectual disability; OCD: Obsessive compulsive disorder; OR: Odds Ratio 
 
 
 
 
 
 
 
